Advantage of Mitigating drug failures is advancing the market for Drug Discovery Informatics

DataM Intelligence presents market research report on ‘Global Drug Discovery Informatics Market – Size, Share and Forecast (2019-2026)’. This report provides expert analysis into the size, scope, magnitude, key players and future trends in this industry. Study by domain specialists determines the market CAGR to be 13.84%

https://www.datamintelligence.com/research-report/drug-discovery-informatics-market

Drug Discovery Informatics Market Dynamics
Key market drivers are an increasing focus on precision medicine, advances in technology which has led to improved data storage, management, processing, and analysis.

Drug companies on an average spend billions of dollars while developing an active drug and failures in this area are expensive.
These failures can be mitigated with efficient data mining and analytics, which further fuel the surge into drug discovery informatics.
https://www.datamintelligence.com/research-report/drug-discovery-informatics-market

Drug Discovery Informatics Market Segmentation
The market is segmented as under.

By Mode- the market is classified into in-house informatics and outsourced informatics.

By Service- the market is classified into sequence analysis platforms, molecular modeling, docking, clinical trial data management, and others.

By Product- the global market is classified into discovery informatics and development informatics.

Drug Discovery Informatics Market Geographical Share
North America accounts for the largest market share. It is due to the extensive research and development of next generation sequencing technologies undertaken by the key market players.

The Asia Pacific is expected to experience the fastest growth primarily due to the increase in the volume of clinical trials being conducted in this region as well as advancements in research software.
Drug Discovery Informatics Market Competition
Collaborations are the primary approach used by key players to expand the portfolio of drug discovery informatics and to improve their market presence.

Infosys developed a cloud-based application to expedite the supply management services for clinical trials, which is anticipated to improve the whole drug design procedure.

In January 2019, Tamr Inc., Scilligence and Clarivate Analytics joined Accenture’s open partner ecosystem, designed to help independent software vendors (ISVs) and life science companies team more effectively to accelerate drug discovery efforts.

Further insights can be obtained by downloading a sample report from the portal below-
https://www.datamintelligence.com/research-report/drug-discovery-informatics-market

The Table of contents contained in this report is as under-
Section 1. Methodology and Scope
Section 2. Industry Trends
Section 3. Market Outlook
Section 4. Market Dynamics
Section 5. Industry Forces
Section 6. Market Segmentation Analysis – By Mode
Section 7. Product-based Analysis
Section 8. Regional, Country-level Analysis
Section 9. Competitive Analysis
Section 10. Company Profiles
Section 11. Global Drug Discovery Informatics Market – Premium Insights

Corporate Address
1st floor, Phoenix Tech Tower, Plot no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana

Email
info@datamintelligence.com

Phone
+1 877-441-4866

About DataM Intelligence
DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.

Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence. This approach not only aligns the findings with historical data but also allows a highly justifiable forecast model.

This release was published on openPR.